Reed’s Schedules Third Quarter 2025 Conference Call for November 4 at 8:30 a.m. ET

(Other OTC:REED),(OTC US:REED), NORWALK, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) — Reed's, Inc. (OTCQX: REED) (“Reed's” or the “Company”), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Tuesday, November 4, 2025, at 8:30 a.m. Eastern time to discuss its financial results for the three and nine […]

Teekay Group to Announce Third Quarter 2025 Earnings Results on October 29, 2025

Teekay Group to Announce Third Quarter 2025 Earnings Results on October 29, 2025 GlobeNewswire October 21, 2025 HAMILTON, Bermuda, Oct. 21, 2025 (GLOBE NEWSWIRE) — Teekay Corporation Ltd. (Teekay) (NYSE:TK) and Teekay Tankers Ltd. (Teekay Tankers) (NYSE:TNK) (collectively, the Teekay Group) plan to release their financial results for the third quarter 2025 after market close

Grocery Outlet Holding Corp. Announces Third Quarter Fiscal 2025 Earnings Release and Conference Call Date

Grocery Outlet Holding Corp. Announces Third Quarter Fiscal 2025 Earnings Release and Conference Call Date GlobeNewswire October 21, 2025 EMERYVILLE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet”) today announced that its financial results for the third quarter of fiscal 2025 will be released after the market close

Adamas Trust 2025 Third Quarter Conference Call Scheduled for Thursday, October 30, 2025

Adamas Trust 2025 Third Quarter Conference Call Scheduled for Thursday, October 30, 2025 GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — Adamas Trust, Inc. (Nasdaq: ADAM) (the “Company”) is scheduled to report financial results for the three and nine months ended September 30, 2025 after the close of market on October

Chemung Financial Corporation Reports Third Quarter 2025 Net Income of $7.8 million, or $1.62 per share

Chemung Financial Corporation Reports Third Quarter 2025 Net Income of $7.8 million, or $1.62 per share GlobeNewswire October 21, 2025 ELMIRA, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) — Chemung Financial Corporation (the “Corporation”) (Nasdaq: CHMG), the parent company of Chemung Canal Trust Company (the “Bank”), today reported net income of $7.8 million, or $1.62 per

Ramaco Resources, Inc. to Release Third Quarter 2025 Financial Results on Monday, October 27, 2025 and Host Conference Call and Webcast on Tuesday, October 28, 2025

Ramaco Resources, Inc. (NASDAQ: METC, METCB, “Ramaco” or the “Company”) will report third quarter 2025 financial results on Monday, October 27, 2025 after the close of market. The earnings news release will be available on the Company's investor relations website atwww.ramacoresources.com and through major financial information sites. At 9:00 a.m. Eastern Time on Tuesday, October

Orrstown Financial Services, Inc. Reports Third Quarter 2025 Results

Orrstown Financial Services, Inc. Reports Third Quarter 2025 Results GlobeNewswire October 21, 2025 Net income of $21.9 million, or $1.13 per diluted share, for the three months ended September 30, 2025 compared to net income of $19.4 million, or $1.01 per diluted share, for the three months ended June 30, 2025; excluding the impact of

Sherwin-Williams Declares Dividend of $0.79 per Common Share

The Board of Directors of The Sherwin-Williams Company (NYSE: SHW) today announced a regular quarterly dividend of $0.79 per common share payable on December 5, 2025, to shareholders of record on November 14, 2025. https://mma.prnewswire.com/media/346043/The_Sherwin_Williams_Company_Logo.jpg Investor Relations Contacts: Media Contact:JimJaye Julie YoungSenior Vice President, Investor Relations & Vice President, Global CorporateCorporate Communications CommunicationsSherwin-Williams Sherwin-WilliamsDirect: 216.515.8682

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire October 21, 2025 CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on October 15, 2025 to 19 new

Scroll to Top